/ Print /


Groundbreaking gene therapies in store for hemophiliaTreatment failures can result in a spectrum of problems for patients with hemophilia. Here’s some guidance on choosing the right therapy.
Four barriers to value-based careStudy reveals growing acceptance of value-based payments among family physicians, but barriers still exist.
Is end-of-life care the place for big data?
Is end-of-life care the place for big data?The benefits and drawbacks of predictive modeling in end-of-life care decision making.
Some Consumers Set to Receive Complimentary Cancer Genomic ProfilingShift represents growing understanding of value of genetic testing for cancers. Find out who is receiving the test and why.
Amazon, JPMorgan, Berkshire Hathaway collaboration puts insurers ‘on notice’Corporate giants Amazon, Berkshire Hathaway, and JPMorgan Chase, partner to shake things up in U.S. employee healthcare.
Seven Ways to Help Patients Access Costly Cancer DrugsTwo new studies reveal that cost-restraints can keep patients from accessing life-preserving cancer drugs.
Cancer Vaccine to Prevent Breast, Ovarian Cancer Recurrence Could be CloseIn partnership with the several big-name cancer centers, one company has commenced clinical trials. Find out how this cancer vaccine would work.
How a customized COPD care bundle is reducing readmissionsReducing readmissions for chronic obstructive pulmonary disease (COPD) is an ongoing challenge for healthcare systems. Here’s how one is successful.
Four pain management programs curbing the opioid epidemicFrom State-led programs to innovative pharmacist-hospital partnerships, these programs are fighting to quell the epidemic.
Four reasons COPD patients don’t receive the right treatmentsMany providers are overlooking important steps that can help guide proper COPD treatment and therefore, reduce admissions and readmissions.